Published in Immunotherapy Weekly, November 2nd, 2005
Under the agreement, NIAID, part of the U.S. National Institutes of Health, and MedImmune of Gaithersburg, Maryland, will produce and test multiple vaccines against potential pandemic flu strains, including the H5N1 avian influenza virus.
Kanta Subbarao, MD MPH, and Brian Murphy, MD, of NIAID's Laboratory of Infectious...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly